Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma
Authors
Keywords
-
Journal
LARYNGOSCOPE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-01-02
DOI
10.1002/lary.28441
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1
- (2019) Thomas J. Ow et al. Oncotarget
- Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma
- (2019) Dana Prukova et al. CLINICAL CANCER RESEARCH
- ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma
- (2018) Yujie Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib
- (2018) Carlyn Rose C. Tan et al. CLINICAL PHARMACOKINETICS
- In HPV-Positive HNSCC Cells, Functional Restoration of the p53/p21 Pathway by Proteasome Inhibitor Bortezomib Does Not Affect Radio- or Chemosensitivity
- (2018) Steve Seltzsam et al. Translational Oncology
- Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
- (2017) Akane Inoue-Yamauchi et al. Nature Communications
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer
- (2015) Shuraila F. Zerp et al. Radiation Oncology
- Mcl-1 is an important therapeutic target for oral squamous cell carcinomas
- (2015) Santanu Maji et al. Oncotarget
- Tobacco smoking alters the number of oral epithelial cells with apoptotic features
- (2014) Adam Michcik et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Single-agent obatoclax (GX15-070) potently induces apoptosis and pro-survival autophagy in head and neck squamous cell carcinoma cells
- (2013) Victor Y. Yazbeck et al. ORAL ONCOLOGY
- Carfilzomib and ONX 0912 Inhibit Cell Survival and Tumor Growth of Head and Neck Cancer and Their Activities Are Enhanced by Suppression of Mcl-1 or Autophagy
- (2012) Y. Zang et al. CLINICAL CANCER RESEARCH
- Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of
- (2012) Jill Gilbert et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Disruptive TP53 Mutation Is Associated with Aggressive Disease Characteristics in an Orthotopic Murine Model of Oral Tongue Cancer
- (2011) D. Sano et al. CLINICAL CANCER RESEARCH
- Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
- (2011) N. Agrawal et al. SCIENCE
- The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
- (2011) N. Stransky et al. SCIENCE
- Bcl2 and Human Papilloma Virus 16 as Predictors of Outcome following Concurrent Chemoradiation for Advanced Oropharyngeal Cancer
- (2010) A. C. Nichols et al. CLINICAL CANCER RESEARCH
- The role of mutant p53 in human cancer
- (2010) Amanda M Goh et al. JOURNAL OF PATHOLOGY
- Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma
- (2009) W. A. Michaud et al. CLINICAL CANCER RESEARCH
- ABT-737 Synergizes with Chemotherapy to Kill Head and Neck Squamous Cell Carcinoma Cells via a Noxa-Mediated Pathway
- (2009) R. Li et al. MOLECULAR PHARMACOLOGY
- Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor- B and activator protein-1 related mechanisms
- (2008) Z. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells
- (2008) Changyou Li et al. MOLECULAR CANCER THERAPEUTICS
- Bcl-2 family proteins and cancer
- (2008) K W Yip et al. ONCOGENE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started